Broad Spectrum RNAi Antiviral against Hemorrhagic Fever Virus

Alnylam Pharmaceuticals, Cambridge MA

Investigators

Abstract

This contract supports research to advance the development of therapeutics against selected NIAID Category A, B, and C viral pathogens via a focused, staged approach.